Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Peptide-based Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Peptide-based Drugmarket, defines the market attractiveness level of Peptide-based Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Peptide-based Drug industry, describes the types of Peptide-based Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Peptide-based Drug market and the development prospects and opportunities of Peptide-based Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Peptide-based Drug market in Chapter 13.
By Player:
AstraZeneca
Eli Lilly
Novartis
Takeda
Ferring
Ipsen
Novo Nordisk
Teva
Sanofi
J & J
The Medicines
Merck
AbbVie
By Type:
Injection
Oral
Other
By End-User:
Cancer
Metabolic Disorders
Central Nervous System
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Peptide-based Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Peptide-based Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Peptide-based Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Peptide-based Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Peptide-based Drug Market Analysis and Outlook to 2022
-
7.1 Global Peptide-based Drug Consumption (2017-2022)
-
7.2 United States Peptide-based Drug Consumption (2017-2022)
-
7.3 Europe Peptide-based Drug Consumption (2017-2022)
-
7.4 China Peptide-based Drug Consumption (2017-2022)
-
7.5 Japan Peptide-based Drug Consumption (2017-2022)
-
7.6 India Peptide-based Drug Consumption (2017-2022)
-
7.7 South Korea Peptide-based Drug Consumption (2017-2022)
8 Region and Country-wise Peptide-based Drug Market Analysis and Outlook to 2028
-
8.1 Global Peptide-based Drug Consumption Forecast (2022-2028)
-
8.2 United States Peptide-based Drug Consumption Forecast (2022-2028)
-
8.3 Europe Peptide-based Drug Consumption Forecast (2022-2028)
-
8.4 China Peptide-based Drug Consumption Forecast (2022-2028)
-
8.5 Japan Peptide-based Drug Consumption Forecast (2022-2028)
-
8.6 India Peptide-based Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Peptide-based Drug Consumption Forecast (2022-2028)
9 Global Peptide-based Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Peptide-based Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Injection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Peptide-based Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Central Nervous System Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Peptide-based Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Peptide-based Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Peptide-based Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Central Nervous System Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Peptide-based Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Peptide-based Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Peptide-based Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Peptide-based Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Peptide-based Drug Market Competitive Analysis
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Details
-
14.1.2 AstraZeneca Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Peptide-based Drug Product and Service
-
14.2 Eli Lilly
-
14.2.1 Eli Lilly Company Details
-
14.2.2 Eli Lilly Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eli Lilly Peptide-based Drug Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Peptide-based Drug Product and Service
-
14.4 Takeda
-
14.4.1 Takeda Company Details
-
14.4.2 Takeda Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Takeda Peptide-based Drug Product and Service
-
14.5 Ferring
-
14.5.1 Ferring Company Details
-
14.5.2 Ferring Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Ferring Peptide-based Drug Product and Service
-
14.6 Ipsen
-
14.6.1 Ipsen Company Details
-
14.6.2 Ipsen Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Ipsen Peptide-based Drug Product and Service
-
14.7 Novo Nordisk
-
14.7.1 Novo Nordisk Company Details
-
14.7.2 Novo Nordisk Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novo Nordisk Peptide-based Drug Product and Service
-
14.8 Teva
-
14.8.1 Teva Company Details
-
14.8.2 Teva Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Teva Peptide-based Drug Product and Service
-
14.9 Sanofi
-
14.9.1 Sanofi Company Details
-
14.9.2 Sanofi Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sanofi Peptide-based Drug Product and Service
-
14.10 J & J
-
14.10.1 J & J Company Details
-
14.10.2 J & J Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 J & J Peptide-based Drug Product and Service
-
14.11 The Medicines
-
14.11.1 The Medicines Company Details
-
14.11.2 The Medicines Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 The Medicines Peptide-based Drug Product and Service
-
14.12 Merck
-
14.12.1 Merck Company Details
-
14.12.2 Merck Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Merck Peptide-based Drug Product and Service
-
14.13 AbbVie
-
14.13.1 AbbVie Company Details
-
14.13.2 AbbVie Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 AbbVie Peptide-based Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Peptide-based Drug
-
Figure Peptide-based Drug Picture
-
Table Global Peptide-based Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide-based Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide-based Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Peptide-based Drug Consumption by Country (2017-2022)
-
Figure United States Peptide-based Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Peptide-based Drug Consumption and Growth Rate (2017-2022)
-
Figure China Peptide-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Peptide-based Drug Consumption and Growth Rate (2017-2022)
-
Figure India Peptide-based Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Peptide-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Peptide-based Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Peptide-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Peptide-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Peptide-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Peptide-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Peptide-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Peptide-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Central Nervous System Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Central Nervous System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Peptide-based Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Peptide-based Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Peptide-based Drug Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Peptide-based Drug Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Peptide-based Drug Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Peptide-based Drug Product and Service
-
Table Ferring (Foundation Year, Company Profile and etc.)
-
Table Ferring Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ferring Peptide-based Drug Product and Service
-
Table Ipsen (Foundation Year, Company Profile and etc.)
-
Table Ipsen Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen Peptide-based Drug Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Peptide-based Drug Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Peptide-based Drug Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Peptide-based Drug Product and Service
-
Table J & J (Foundation Year, Company Profile and etc.)
-
Table J & J Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table J & J Peptide-based Drug Product and Service
-
Table The Medicines (Foundation Year, Company Profile and etc.)
-
Table The Medicines Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table The Medicines Peptide-based Drug Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Peptide-based Drug Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Peptide-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Peptide-based Drug Product and Service
-
